Boston University Has Developed a '80% FATAL' New Covid Mutant Strain In Lab

U.S. researchers at Boston University have developed a new lethal Covid mutant strain in a laboratory – echoing the type of experiments many fear started the pandemic. Why? It will kill 80% of the people it infects. What is the goal here? Who is financing this?

We are being led by the very worst of humanity.

Boston University researchers claim to have developed new, more lethal COVID strain in lab

Researchers at Boston University added a spike protein from the Omicron variant with the original Wuhan strain, which has an 80% kill rate

By Louis Casiano | Fox News

Researchers at Boston University say they have developed a new COVID strain that has an 80% kill rate following a series of similar experiments first thought to have started the global pandemic that began in China.

The variant, a combination of omicron and the original virus in Wuhan, killed 80% of the mice infected with it, the university said. When mice were only exposed to omicron, they experienced mild symptoms.

The research was conducted by a team of scientists from Florida and Boston at the school’s National Emerging Infectious Diseases Laboratories.

They extracted the spike protein from omicron and attached it with the strain first detected at the onset of the pandemic that began in Wuhan, China. They then documented how the mice reacted to the hybrid strain.

“In…mice, while Omicron causes mild, non-fatal infection, the Omicron S-carrying virus inflicts severe disease with a mortality rate of 80 percent,” they wrote in a research paper.

The new strain has five times more infectious virus particles than the omicron variant, researchers said.

In a statement, the university stressed that the replicated strain was less dangerous than the original strain.

“First, this research is not gain-of-function research, meaning it did not amplify the Washington state SARS-COV-2 virus strain or make it more dangerous. In fact, this research made the virus replicate less dangerous,” the statement read. “Secondly, the research was reviewed and approved by the Institutional Biosafety Committee (IBC), which consists of scientists as well as local community members. The Boston Public Health Commission also approved the research. Furthermore, this research mirrors and reinforces the findings of other, similar research performed by other organizations, including the FDA. Ultimately, this research will provide a public benefit by leading to better, targeted therapeutic interventions to help fight against future pandemics.”

COVID-19 was first detected to have come from a wet market in Wuhan, though many believe the virus was engineered at the Wuhan Institute of Virology. The World Health Organization continues to face criticism for its handling of the crisis in its early, most pivotal, days.

Keep reading.